Cytosorbents (CTSO) Other Non-Current Assets (2010 - 2026)

Cytosorbents' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• Quarterly Other Non-Current Assets changed 0.03% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (changed 0.03% YoY) and the FY2025 annual result came in at $53000.0, down 96.43% from the prior year.
• Other Non-Current Assets was $1.5 million for Q1 2026 at Cytosorbents, up from $53000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $6.5 million in Q3 2024 and bottomed at $53000.0 in Q4 2025.
• A 5-year average of $2.7 million and a median of $1.7 million in 2022 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2024 — Other Non-Current Assets soared 284.24% — and 2025, when it plunged 96.43%.
• Cytosorbents' Other Non-Current Assets stood at $4.4 million in 2022, then plunged by 66.56% to $1.5 million in 2023, then climbed by 0.0% to $1.5 million in 2024, then plunged by 96.43% to $53000.0 in 2025, then surged by 2771.7% to $1.5 million in 2026.
• Business Quant data shows CTSO's Other Non-Current Assets at $1.5 million in Q1 2026, $53000.0 in Q4 2025, and $1.5 million in Q3 2025.